Association between Cardiovascular Risk and Diabetes with Colorectal Neoplasia: A Site-Specific Analysis

• Published in: Journal of clinical medicine 2018-11, Vol.7 (12), p.484
• Main Authors: Niederseer, David, Bracher, Isabelle, Stadlmayr, Andreas, Huber-Schönauer, Ursula, Plöderl, Martin, Obeid, Slayman, Schmied, Christian, Hammerl, Sabrina, Stickel, Felix, Lederer, Dieter, Patsch, Wolfgang, Aigner, Elmar, Datz, Christian
• Format: Article
• Language: English
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm7120484

Several studies have shown site-specific differences in colorectal cancer (CRC) with respect to the risk factors. CRC was shown to be associated with cardiovascular risk (CVR) factors, but site-specific variations have not been investigated so far. This study aimed to assess the associations between the prevalence and subsite-specific differences of colorectal neoplasia and established CVR scores or known coronary artery disease (CAD) in a large asymptomatic European screening cohort ( = 2098). Participants underwent simultaneous screening colonoscopy and CVR evaluation, using the Framingham Risk Score and Heart Score. Lesions found in the colonoscopy were classified by location (proximal/distal colon or rectum). More neoplasias were found in the proximal versus the distal colon ( < 0.001). The Framingham Risk Score and Heart Score showed incremental risk for colorectal adenoma, across the tertiles in the proximal and the distal colon ( < 0.001). The prevalence of adenomas in the rectum was much lower, but also here, incremental risk could be shown for the Framingham Risk but not the Heart Risk Score tertiles. Prevalence of adenomas in the proximal colon was higher in subjects with type 2 diabetes (T2DM) ( = 0.006), but no association was found between adenomas and T2DM in the distal colon ( = 0.618) and the rectum ( = 0.071). Males had a higher CVR and more findings, in the screening colonoscopy, as compared to females, however, no site-specific differences were noted. Patients with known CAD and high CVR have an increased risk of colorectal neoplasia in both the proximal and distal colon. Patients with T2DM have a higher risk for neoplasia in the proximal colon.